Daewoong Pharmaceutical and Sandoz Korea are poised to step up their marketing in the fentanyl transdermal therapeutic systems market, which has been so far dominated by Janssen’s Durogenic.
Daewoong is expected to market Nycomed’s Matrifen of five different strengths (12, 25, 50, 75 and 100 µg/hour), fentanyl transdermal matrix patch, slated for release in early September. Matrifen contains...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.